Showing results (221-230 of 263) with videos related to

Sort By:
Pageof 27
BMC Cancer|May 3, 2020
A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2019
Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancerMidori Shimada, Hiroyuki Yamaguchi, Minoru Fukuda, et al.
The EMBO Journal|June 30, 2011
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycansShigeru Tsuboi, Mihoko Sutoh, Shingo Hatakeyama, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2014
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancerTakaya Ikeda, Minoru Fukuda, Yoichi Nakamura, et al.
Lung Cancer Management|June 7, 2023
Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsyShinnosuke Takemoto, Mutsumi Ozasa, Remi Mizuta, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2016
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutationsKosuke Mizoguchi, Yoichi Nakamura, Kazumi Sano, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 28, 2019
Analysis of A4gnt Knockout Mice Reveals an Essential Role for Gastric Sulfomucins in Preventing Gastritis Cystica ProfundaMasatomo Kawakubo, Hitomi Komura, Yukinobu Goso, et al.
The Journal of Experimental Medicine|December 5, 2012
Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cellsAtsushi Nishida, Kiyotaka Nagahama, Hirotsugu Imaeda, et al.
Oncoimmunology|September 19, 2017
EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunityDiana I Albu, Zichun Wang, Kuan-Chun Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
HMMC-1: a humanized monoclonal antibody with therapeutic potential against Müllerian duct-related carcinomasShiro Nozawa, Daisuke Aoki, Katsumi Tsukazaki, et al.
Pageof 27